Scarica l'app Stockscreener
1.17
2.18%
0.02
Precedente Chiudi:
$1.15
Aprire:
$1.175
Volume 24 ore:
16,258
Relative Volume:
0.10
Capitalizzazione di mercato:
$23.05M
Reddito:
-
Utile/perdita netta:
$-33.08M
Rapporto P/E:
-0.398
EPS:
-2.94
Flusso di cassa netto:
$-25.68M
1 W Prestazione:
-1.55%
1M Prestazione:
-12.31%
6M Prestazione:
-44.83%
1 anno Prestazione:
+21.46%
Intervallo 1D:
$1.16
$1.1899
Intervallo di 1 settimana:
$1.15
$1.2208
Portata 52W:
$0.87
$2.55
Chemomab Therapeutics Ltd Adr Stock (CMMB) Company Profile
Nome
Chemomab Therapeutics Ltd Adr
Settore
Industria
Telefono
972-77-331-0156
Indirizzo
KIRYAT ATIDIM, BUILDING 7, TEL AVIV
Confronta CMMB con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CMMB
Chemomab Therapeutics Ltd Adr
|
1.18 | 23.05M | 0 | -33.08M | -25.68M | -2.94 |
|
VRTX
Vertex Pharmaceuticals Inc
|
459.39 | 115.95B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
549.71 | 56.52B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
330.10 | 39.44B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
542.49 | 35.14B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
246.07 | 28.51B | 3.81B | -644.79M | -669.77M | -6.24 |
Chemomab Therapeutics Ltd Adr Stock (CMMB) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-05-13 | Iniziato | Maxim Group | Buy |
| 2024-05-06 | Aggiornamento | Oppenheimer | Perform → Outperform |
| 2023-12-19 | Ripresa | ROTH MKM | Buy |
Chemomab Therapeutics Ltd Adr Borsa (CMMB) Ultime notizie
CMMB’s Market Whiplash: -34.81% YTD Decline, -15.11% Plunge in 30 Days - investchronicle.com
TPST Stock Up on EMA's Orphan Drug Tag for Liver Cancer Therapy - sharewise
KURA Stock Rises More Than 15% This Past Week: Here's Why - The Globe and Mail
MRK's ADC Drug Combo Shows Antitumor Activity in Lymphoma Study - sharewise
NTLA Stock Down as Patient Faces Adverse Event in Gene Therapy Study - Yahoo Finance
CADL Up as FDA Grants RMAT Status to CAN-2409 in Prostate Cancer - sharewise
RCKT Stock Tanks On Patient Death In Danon Disease Study - Barchart.com
RCKT Stock Tanks on Patient Death in Danon Disease Study - Yahoo Finance
TEVA Begins IND-Enabling Studies on Inflammatory Disease Candidate - Yahoo Finance
Chemomab prepares for annual shareholder meeting By Investing.com - Investing.com India
Chemomab prepares for annual shareholder meeting - Investing.com
Chemomab Leadership Changes Signal Strategic Momentum Following Positive Clinical Results - Barchart.com
HUTCHMED and AstraZeneca Announce that TAGRISSO® Plus Savolitinib Demonstrated 49% Objective Response Rate in Lung Cancer Patients with High Levels of MET Overexpression and/or Amplification in SAVANNAH Phase II Trial - Barchart.com
Microsoft Stock After Xbox Price Hike: Buy Or Hold? - Barchart.com
Should You Buy, Sell, Or Hold Nio Stock Amid Firefly Brand Launch? - Barchart.com
UBS Group Q1 Earnings & Revenues Dip Y/Y, Credit Loss Expenses Slip - Barchart.com
This ‘Strong Buy’ Robotaxi Stock Just Got A Huge Bump. Should You Buy Shares Now? - Barchart.com
Chemomab reports promising PSC treatment data - Investing.com
Chemomab Announces New Medical And Clinical Appointments - Barchart.com
Should You Buy Tesla Stock On The ‘Liberation Day’ Dip? - Barchart.com
Should You Dump Tesla Stock As Deliveries Plunge In Q1 And Tariff Fears Escalate? - Barchart.com
The Aurora Cannabis Inc (NASDAQ: ACB) Stock Price: Is It Overvalued? - Stocks Register
How Stable And Growing Is Globavend Holdings Ltd (NASDAQ: GVH)? - Stocks Register
Before Buying AYRO Inc (NASDAQ: AYRO) Stock, Read This First - Stocks Register
Is Advance Auto Parts Inc (NYSE: AAP) A Good Investment For New Investors Now? - stocksregister.com
Nu Holdings Ltd (NYSE: NU) Has Great Upside Potential - stocksregister.com
ZEEKR Intelligent Technology Holding Ltd. ADR (NYSE: ZK): Getting A Free Pass? - stocksregister.com
AT&T, Inc (NYSE: T) Jumps 1.59%: What Could Be On The Way Going Forward? - Stocks Register
Adma Biologics Inc (NASDAQ: ADMA): Blank Check For Growth? - Stocks Register
A Bullish 2025 Outlook For Blink Charging Co (NASDAQ: BLNK) Shares - Stocks Register
In 2025, Linkers Industries Ltd (NASDAQ: LNKS) Shares Will Likely Be Bullish - Stocks Register
Carrier Global Corp (NYSE: CARR): On Track To A Higher Share Price - Stocks Register
Before Buying Avantor Inc (NYSE: AVTR) Stock, Read This First - stocksregister.com
Ally Financial Inc (NYSE: ALLY): An Enticing Stock To Watch - stocksregister.com
Nebokitug shows promise in PSC treatment trial - Investing.com
Q3 Rundown: Sea (NYSE:SE) Vs Other Online Marketplace Stocks - Barchart.com
Does DLocal Limited (NASDAQ: DLO) Still Need To Convince Analysts? - stocksregister.com
Think You Need A Good Stock? Look At This Scilex Holding Company (NASDAQ: SCLX) Analysis - stocksregister.com
Centessa Pharmaceuticals plc ADR (NASDAQ: CNTA)’s Stock Boosts 3.25%, But It May Be A Worthy Investment - stocksregister.com
Is WeRide Stock A Buy, Sell, Or Hold As Nvidia Reveals Its $25 Million Bet? - Barchart.com
Chemomab Therapeutics (CMMB) Stock Price, News & Analysis - MarketBeat
How analysts predict Chemomab Therapeutics Ltd ADR (CMMB) will perform this quarter? - US Post News
Nebokitug positioned as potential first FDA-approved PSC treatment By Investing.com - Investing.com South Africa
Arm Just Nabbed A Major Chip Deal With Meta. Is ARM Stock A Buy, Sell, Or Hold Now? - Barchart.com
Nvidia Sends Chinese Self-Driving Stock Up 100%, While Soundhound AI Sells Off - Barchart.com
Up 175% In 2024, Can This Growth Stock Keep Climbing? - Barchart.com
3 Stocks To Benefit From China’s Rare Earth Export Ban On U.S. - Barchart.com
LogicMark Inc (LGMK) Recovers 0.71% From Low: Are We There Yet? - Stocks Register
Is Toyota Stock A Buy, Sell, Or Hold On New Return On Equity Plans? - Barchart.com
3 Pharma Stocks To Buy As California Sounds The Alarm On Bird Flu Cases - Barchart.com
What's Going On With Alibaba Stock? - Barchart.com
Chemomab Therapeutics Ltd Adr Azioni (CMMB) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.34%
7.69%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):